BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teng F, Zhang JX, Chang QM, Wu XB, Tang WG, Wang JF, Feng JF, Zhang ZP, Hu ZQ. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res 2020;39:235. [PMID: 33168027 DOI: 10.1186/s13046-020-01739-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Yang M. The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3740. [PMID: 34359642 DOI: 10.3390/cancers13153740] [Reference Citation Analysis]
2 Teng F, Zhang JX, Chang QM, Wu XB, Tang WG, Wang JF, Feng JF, Zhang ZP, Hu ZQ. Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res 2020;39:277. [PMID: 33298087 DOI: 10.1186/s13046-020-01780-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Xie D, Pei Q, Li J, Wan X, Ye T. Emerging Role of E2F Family in Cancer Stem Cells. Front Oncol 2021;11:723137. [PMID: 34476219 DOI: 10.3389/fonc.2021.723137] [Reference Citation Analysis]
4 Zeng H, Wei Y, Wei X, Feng R. LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p. Cancer Manag Res 2021;13:3589-99. [PMID: 33958893 DOI: 10.2147/CMAR.S299715] [Reference Citation Analysis]
5 Yu L, Li W, Yang P, Zhang W, Tao H, Ge G, Yang H, Bai J, Wang H, Geng D. Osteoblastic microRNAs in skeletal diseases: Biological functions and therapeutic implications. Engineered Regeneration 2022. [DOI: 10.1016/j.engreg.2022.06.002] [Reference Citation Analysis]
6 Chen ZA, Tian H, Yao DM, Zhang Y, Feng ZJ, Yang CJ. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Front Oncol 2021;11:738477. [PMID: 34568075 DOI: 10.3389/fonc.2021.738477] [Reference Citation Analysis]
7 Lv HC, Lv YY, Wang G, Zhang XH, Li SN, Yue XF, Lu W. Mechanism of miR-424-5p promoter methylation in promoting epithelial-mesenchymal transition of hepatocellular carcinoma cells. Kaohsiung J Med Sci 2022. [PMID: 35049148 DOI: 10.1002/kjm2.12499] [Reference Citation Analysis]
8 Yan G, Chang Z, Wang C, Gong Z, Xin H, Liu Z. LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628-5p/MEIS2 axis to activate the Notch pathway. Dig Liver Dis 2021:S1590-8658(21)00221-8. [PMID: 34053876 DOI: 10.1016/j.dld.2021.04.036] [Reference Citation Analysis]
9 Liu Y, Wang G, Li Y, Zhao Q, Fan L, Tan B, Li B, Yu B, Xi J. miR-424-5p reduces 5-fluorouracil resistance possibly by inhibiting Src/focal adhesion kinase signalling-mediated epithelial-mesenchymal transition in colon cancer cells. J Pharm Pharmacol 2021;73:1062-70. [PMID: 33793771 DOI: 10.1093/jpp/rgab031] [Reference Citation Analysis]
10 Li Y, Tian M, Zhang D, Zhuang Y, Li Z, Xie S, Sun K. Long Non-Coding RNA Myosin Light Chain Kinase Antisense 1 Plays an Oncogenic Role in Gallbladder Carcinoma by Promoting Chemoresistance and Proliferation. Cancer Manag Res 2021;13:6219-30. [PMID: 34393514 DOI: 10.2147/CMAR.S323759] [Reference Citation Analysis]
11 Zhu X, Feng Y, He D, Wang Z, Huang F, Tu J. Clinical Value and Underlying Mechanisms of Upregulated LINC00485 in Hepatocellular Carcinoma. Front Oncol 2021;11:654424. [PMID: 34290977 DOI: 10.3389/fonc.2021.654424] [Reference Citation Analysis]
12 Shi Y, Zhang DD, Liu JB, Yang XL, Xin R, Jia CY, Wang HM, Lu GX, Wang PY, Liu Y, Li ZJ, Deng J, Lin QL, Ma L, Feng SS, Chen XQ, Zheng XM, Zhou YF, Hu YJ, Yin HQ, Tian LL, Gu LP, Lv ZW, Yu F, Li W, Ma YS, Da F. Comprehensive analysis to identify DLEU2L/TAOK1 axis as a prognostic biomarker in hepatocellular carcinoma. Mol Ther Nucleic Acids 2021;23:702-18. [PMID: 33575116 DOI: 10.1016/j.omtn.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. J Exp Clin Cancer Res 2021;40:299. [PMID: 34551796 DOI: 10.1186/s13046-021-02090-7] [Reference Citation Analysis]
14 Ma X, Mo M, Tan C, Tan JHJ, Huang H, Liu B, Huang D, Liu S, Zeng X, Qiu X. Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo. J Transl Med 2022;20. [DOI: 10.1186/s12967-021-03225-2] [Reference Citation Analysis]
15 Zhang DD, Shi Y, Liu JB, Yang XL, Xin R, Wang HM, Wang PY, Jia CY, Zhang WJ, Ma YS, Fu D. Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma. Mol Ther Nucleic Acids 2021;24:1033-50. [PMID: 34141458 DOI: 10.1016/j.omtn.2021.04.019] [Reference Citation Analysis]
16 Wu Y, Yuan J, Tu Z, Chen H, Wu X. CircLATS2 Regulates miR-520a-3p/E2F7/p-VEGFR2 Signaling Pathway to Promote Hepatocellular Carcinoma Progression and Angiogenesis. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3744560] [Reference Citation Analysis]
17 Wei X, Hou Y, Zhang Y, Zhang H, Sun Z, Meng X, Wang Z. Long non-coding RNA MAGI2-AS3 inactivates STAT3 pathway to inhibit prostate cancer cell proliferation via acting as a microRNA-424-5p sponge. J Cancer 2022;13:343-53. [PMID: 34976194 DOI: 10.7150/jca.60749] [Reference Citation Analysis]
18 Zhang S, Xu J, Chen Q, Zhang F, Wang H, Guo H. lncRNA MT1JP-overexpression abolishes the silencing of PTEN by miR-32 in hepatocellular carcinoma. Oncol Lett 2021;22:604. [PMID: 34188706 DOI: 10.3892/ol.2021.12865] [Reference Citation Analysis]
19 Wong LS, Wong CM. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma. Int J Mol Sci 2021;22:3137. [PMID: 33808647 DOI: 10.3390/ijms22063137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Shi T, Morishita A, Kobara H, Masaki T. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci 2021;22:10630. [PMID: 34638971 DOI: 10.3390/ijms221910630] [Reference Citation Analysis]